Jessica Grainger Shares Her Story with Paddy Gower on TFN

Jessica Grainger bravely shared her journey on Paddy Gower, TFN, shining a light on the realities of living with a chronic condition, such as Hydrocephalus, and the need for proactive health care management.

We’ve had the privilege of working with Jessica as part of the The University of Auckland first-in-human clinical trial at Auckland Hospital. The Kitea Health System has the potential to improve outcomes for patients living with chronic conditions.

For families facing the daily challenges of chronic illness, that shift can make all the difference. This story shines a light on the potential impact of Kitea’s technology and the compassionate drive behind it. To view the episode: https://www.stuff.co.nz/nz-news/paddy-gowers-tfn

Kitea Health Soars as a Hi-Tech Awards Finalist!

Kitea Health has been named a finalist in the Aware Group (an HSO Company) Most Innovative Deep Tech Solution category at the prestigious New Zealand Hi-Tech Awards!

For those unfamiliar, the Hi-Tech Awards are a cornerstone of the New Zealand technology sector, recognizing and celebrating the very best in innovation and achievement. With hundreds of companies entering each year, simply being selected as a finalist is a significant accomplishment and a testament to the hard work and dedication of the entire Kitea Health team.

This achievement fuels the companies drive to continue pushing the boundaries of what's possible in healthcare technology. It's great to see this recognition and excited to see what the future holds for Kitea Health and the entire New Zealand deep tech community.

Neuro Health Expert with Proven Commercialization and Acquisition Success Joins Kitea Health Board: Prattitpati Laxminarain

Kitea Health is pleased to welcome P. (Laxmin) Laxminarain to our Board of Directors. With over 3 decades of leadership experience in Johnson & Johnson including as Worldwide President of Codman Neuro, as well as over 7 years serving on Boards for neuro health and medical technology companies including GT Medical, Microbot Medical, Oculogica and Millar, he brings a wealth of knowledge and strategic expertise. His proven reputation in the medical technology industry as well as his deep understanding of the neuro health and medical devices market will be invaluable to Kitea Health as we grow and innovate. We look forward to his active involvement in our Board as we drive our technology to market to reach neuro patients worldwide, and in building Kitea Health’s value.